Trials / Not Yet Recruiting
Not Yet RecruitingNCT07420465
Cardiometabolic Risk in Pregnancy and Postpartum
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Forgive Avorgbedor · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to evaluate changes in blood pressure and early cardiovascular risk markers and to determine whether a postpartum education intervention can improve cardiovascular risk monitoring among pregnant women in their third trimester through six months postpartum in Accra, Ghana. The study includes women aged 18 years and older with and without pregnancy-related cardiometabolic complications. Findings from this study will inform the development of scalable postpartum screening and intervention strategies to reduce long-term cardiovascular disease risk among women.
Conditions
- Hypertensive Disorders of Pregnancy
- Postpartum Hypertension
- Cardiovascular Disease Risk
- High Blood Pressure
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Postpartum Cardiovascular Disease (CVD) Risk Reduction Program | The PP-CVD Risk Reduction Program is a structured cardiovascular disease risk-reduction program that includes home blood pressure monitoring and weekly postpartum education sessions on heart health after pregnancy, nutrition, physical activity, stress management, sleep, weight management, medication adherence, and long-term cardiovascular health for postpartum women. |
| BEHAVIORAL | Enhanced Postpartum Care | The Enhanced Postpartum Care intervention is a structured postpartum support program that includes home blood pressure monitoring and scheduled maternal-infant health check-ins, providing education on postpartum recovery, infant care, mental health, nutrition, infection prevention, and family planning to support maternal health during the postpartum period. |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2027-06-28
- Completion
- 2027-12-01
- First posted
- 2026-02-19
- Last updated
- 2026-02-19
Locations
1 site across 1 country: Ghana
Source: ClinicalTrials.gov record NCT07420465. Inclusion in this directory is not an endorsement.